Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kohga K et al. – Anticancer drugs can modulate expression of ADAM10, which is critically involved in MICA ectodomain shedding. Epirubicin therapy may have a previously unrecognized effect on antitumor immunity in HCC patients.

Related Articles

Introducing a new entity: chemotherapy-induced arrhythmia
Europace, 10/16/09    Relevance Score: 65%

Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid
Journal of Pharmacy and Pharmacology, 10/15/09    Relevance Score: 65%

Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09    Relevance Score: 65%

Expression of ERCC1 and class IIIbeta tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer
Pathology International, 10/30/09    Relevance Score: 64%

A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
Cancer, 11/09/09    Relevance Score: 46%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address